Your cart is empty.
Zurich, Switzerland, 19 June 2002 – Tecan, a leading player in the Life Science supply industry, today announced that it will hold its second Innovation Day on September 19th, 2002, at the company’s fully operational Proteomics laboratory in Munich, Germany. At the Innovation Day, Tecan will demonstrate new products that target key applications in proteomic research. In addition, the company will present an update on its business developments, market position and strategy.
The convergence of new technologies, throughput capabilities and informatics is enabling a revolution in the study of proteins. The breakthrough solutions being developed in proteomic research today parallel the profound advances that were made in the genomic revolution of the early 1990s. However, the complexity and dynamic nature of proteomes poses considerable new challenges to the development of technological solutions capable of overcoming key bottlenecks in proteomic research.
The Innovation Day will reveal how Tecan’s expertise in automation, robotics, fractionation, protein identification and protein characterization are being used to provide workstations and solutions that will systematically remove many of the major barriers facing the proteomics industry.
Earlier this year Tecan recorded its first sales in this business area with the introduction of the ProTeam™ FFE. The ProTeam™ FFE is a revolutionary technology that, for the first time, enables researchers to achieve the reproducibility and sensitivity necessary to study the complexity of the proteome. The ProTeam™ FFE offers unrivalled access to low-abundant proteins due to its capability for continuous sample application. The forthcoming ProTeam™ suite of products will provide solutions that span the whole range of methods needed for protein identification, separation and characterization and will provide a complete platform of technologies for proteomic researchers.
Through its Innovation Day, Tecan would like to communicate some of the exciting developments that it believes will shape the proteomics industry in the coming years. We look forward to welcoming you to Tecan Munich.
Tecan (www.tecan.com) is a leading player in the Life Sciences supply industry that specializes in the development, production, and distribution of solutions enabling the discovery of pharmaceutical substances, as well as for genomics, proteomics, and diagnostics. Tecan clients are leading pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2001, Tecan achieved sales of CH 361.9 million (USD 214.1 million; EUR 239.6 million). Registered shares of Tecan Group are traded on the Swiss SWX stock exchange (TK: TECN / Reuters: TECZn.S / Valor : 1210019).